Sublingual Immunotherapy Safe, Effective For Treating Toddlers’ Peanut Allergy
[Source: Medical X-Press]
Peanut sublingual immunotherapy (SLIT) is safe and effective at inducing desensitization and remission in 1- to 4-year-old children, according to a study published online Oct. 10 in the Journal of Allergy and Clinical Immunology.
Edwin H. Kim, M.D., from the University of North Carolina at Chapel Hill, and colleagues studied the safety and efficacy of SLIT for peanut allergy in 1- to 4-year-old children. The analysis included 50 participants randomly assigned to SLIT or placebo.
Read the Rest of this Article Medical X-Press
PediaStaff is Hiring!
All JobsPediaStaff hires pediatric and school-based professionals nationwide for contract assignments of 2 to 12 months. We also help clinics, hospitals, schools, and home health agencies to find and hire these professionals directly. We work with Speech-Language Pathologists, Occupational and Physical Therapists, School Psychologists, and others in pediatric therapy and education.